Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype

M. Zaliova, M. Kotrova, S. Bresolin, J. Stuchly, J. Stary, O. Hrusak, G. Te Kronnie, J. Trka, J. Zuna, M. Vaskova,

. 2017 ; 56 (8) : 608-616. [pub] 20170505

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016675

Grantová podpora
NV15-30626A MZ0 CEP - Centrální evidence projektů

We have shown previously that ETV6/RUNX1-positive acute lymphoblastic leukemia (ALL) is distinguishable from other ALL subtypes by CD27pos /CD44low-neg immunophenotype. During diagnostic immunophenotyping of 573 childhood B-cell precursor ALL (BCP-ALL), we identified eight cases with this immunophenotype among "B-other ALL" (BCP-ALL cases negative for routinely tested chromosomal/genetic aberrations). We aimed to elucidate whether these cases belong to the recently described ETV6/RUNX1-like ALL defined by the ETV6/RUNX1-specific gene expression profile (GEP), harboring concurrent ETV6 and IKZF1 lesions. We performed comprehensive genomic analysis using single nucleotide polymorphism arrays, whole exome and transcriptome sequencing and GEP on microarrays. In unsupervised hierarchical clustering based on GEP, five out of seven analyzed CD27pos /CD44low-neg B-other cases clustered with ETV6/RUNX1-positive ALL and were thus classified as ETV6/RUNX1-like ALL. The two cases clustering outside ETV6/RUNX1-positive ALL harbored a P2RY8/CRLF2 fusion with activating JAK2 mutations and a TCF3/ZNF384 fusion, respectively, assigning them to other ALL subtypes. All five ETV6/RUNX1-like cases harbored ETV6 deletions; uniform intragenic ARPP21 deletions and various IKZF1 lesions were each found in three ETV6/RUNX1-like cases. The frequency of ETV6 and ARPP21 deletions was significantly higher in ETV6/RUNX1-like ALL compared with a reference cohort of 42 B-other ALL. In conclusion, we show that ETV6/RUNX1-like ALL is associated with CD27pos /CD44low-neg immunophenotype and identify ARPP21 deletions to contribute to its specific genomic profile enriched for ETV6 and IKZF1 lesions. In conjunction with previously published data, our study identifies the ETV6 lesion as the only common genetic aberration and thus the most likely key driver of ETV6/RUNX1-like ALL.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016675
003      
CZ-PrNML
005      
20180516135216.0
007      
ta
008      
180515s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/gcc.22464 $2 doi
035    __
$a (PubMed)28395118
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Zaliova, Marketa $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
245    10
$a ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype / $c M. Zaliova, M. Kotrova, S. Bresolin, J. Stuchly, J. Stary, O. Hrusak, G. Te Kronnie, J. Trka, J. Zuna, M. Vaskova,
520    9_
$a We have shown previously that ETV6/RUNX1-positive acute lymphoblastic leukemia (ALL) is distinguishable from other ALL subtypes by CD27pos /CD44low-neg immunophenotype. During diagnostic immunophenotyping of 573 childhood B-cell precursor ALL (BCP-ALL), we identified eight cases with this immunophenotype among "B-other ALL" (BCP-ALL cases negative for routinely tested chromosomal/genetic aberrations). We aimed to elucidate whether these cases belong to the recently described ETV6/RUNX1-like ALL defined by the ETV6/RUNX1-specific gene expression profile (GEP), harboring concurrent ETV6 and IKZF1 lesions. We performed comprehensive genomic analysis using single nucleotide polymorphism arrays, whole exome and transcriptome sequencing and GEP on microarrays. In unsupervised hierarchical clustering based on GEP, five out of seven analyzed CD27pos /CD44low-neg B-other cases clustered with ETV6/RUNX1-positive ALL and were thus classified as ETV6/RUNX1-like ALL. The two cases clustering outside ETV6/RUNX1-positive ALL harbored a P2RY8/CRLF2 fusion with activating JAK2 mutations and a TCF3/ZNF384 fusion, respectively, assigning them to other ALL subtypes. All five ETV6/RUNX1-like cases harbored ETV6 deletions; uniform intragenic ARPP21 deletions and various IKZF1 lesions were each found in three ETV6/RUNX1-like cases. The frequency of ETV6 and ARPP21 deletions was significantly higher in ETV6/RUNX1-like ALL compared with a reference cohort of 42 B-other ALL. In conclusion, we show that ETV6/RUNX1-like ALL is associated with CD27pos /CD44low-neg immunophenotype and identify ARPP21 deletions to contribute to its specific genomic profile enriched for ETV6 and IKZF1 lesions. In conjunction with previously published data, our study identifies the ETV6 lesion as the only common genetic aberration and thus the most likely key driver of ETV6/RUNX1-like ALL.
650    _2
$a mladiství $7 D000293
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a protein PEBP2A2 $x genetika $7 D050676
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a antigeny CD44 $x genetika $x metabolismus $7 D018960
650    _2
$a imunofenotypizace $7 D016130
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a fúzní onkogenní proteiny $x genetika $7 D015514
650    12
$a fenotyp $7 D010641
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a akutní lymfatická leukemie $x krev $x genetika $x imunologie $7 D054198
650    _2
$a antigeny CD27 $x genetika $x metabolismus $7 D018127
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kotrova, Michaela $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
700    1_
$a Bresolin, Silvia $u Department of Women's and Children's Health, University of Padova, Italy.
700    1_
$a Stuchly, Jan $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Stary, Jan $u Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
700    1_
$a Hrusak, Ondrej $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
700    1_
$a Te Kronnie, Geertruy $u Department of Women's and Children's Health, University of Padova, Italy.
700    1_
$a Trka, Jan $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
700    1_
$a Zuna, Jan $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic. University Hospital Motol, Prague, Czech Republic.
700    1_
$a Vaskova, Martina $u CLIP-Childhood Leukaemia Investigation Prague, Czech Republic. Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00001898 $t Genes, chromosomes & cancer $x 1098-2264 $g Roč. 56, č. 8 (2017), s. 608-616
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28395118 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180516135351 $b ABA008
999    __
$a ok $b bmc $g 1300299 $s 1013515
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 56 $c 8 $d 608-616 $e 20170505 $i 1098-2264 $m Genes, chromosomes & cancer $n Genes Chromosom Cancer $x MED00001898
GRA    __
$a NV15-30626A $p MZ0
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...